• Manufacturing

Press Release: Over £100m cash boost to manufacture millions of doses of COVID-19 vaccine

- New state-of-the-art centre to scale up COVID-19 vaccine and gene therapy manufacturing gets £100m investment - Additional £4.7m for new training facilities and an online learning platform to boost vaccine as well as cell and gene therapy skills - New centre and skills vital for the UK’s ability respond to diseases like coronavirus, and potential future pandemics

CGT Catapult Annual Review 2020 highlights impact on growth and productivity in the UK cell and gene therapy industry

The 2020 annual report released today presents Cell and Gene Therapy Catapult's achievements, collaborations and initiatives from the past year and their impact in enhancing growth, productivity and supporting the development and commercialisation of cell and gene therapies.

RoslinCT announces the construction of a new Cell & Gene therapy manufacturing facility

RoslinCT - a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) - announces initiation of construction for the expansion of their new manufacturing centre.

Life Sciences Recovery Roadmap

The COVID-19 crisis has powerfully demonstrated the strategic importance of the life science sector to the UK’s health, security, and to the economy.

Achilles Therapeutics to set up manufacturing operations at the CGT Catapult manufacturing centre

The collaboration will see Achilles Therapeutics expand their manufacturing footprint at the CGT Catapult manufacturing centre to supply clinical trials of their novel T cell therapy products. Onboarding has begun into one of the newly operational modules at the state-of-the-art facility.

MicrofluidX raises £1.4m in seed funding to develop novel cell therapy bioprocessing technology Primary tabs

MicrofluidX announces it has raised £1.4m in seed funding to develop its novel cell bioprocessing technology, utilising microfluidics to tackle the challenges associated with bioprocessing for cell and gene therapy.

Fieldfisher Life Sciences sector group mobilises to offer pro bono legal advice for COVID-19

Fieldfisher are delighted to announce that their pan-European Life Sciences sector group have mobilised to show support for life science companies contributing efforts towards global pandemic COVID-19.

UCL supports worldwide dissemination of free-to-access manufacturing instructions for COVID-19 breathing aids

Governments across the world, healthcare providers and device manufacturers can now request a free of charge licence to the design and manufacturing files of a breathing aid developed by UCL, UCLH and Mercedes-AMG High Performance Powertrains (Mercedes-AMG HPP) to support healthcare systems preparing for the Covid-19 pandemic.

Cobra Biologics successfully completes key milestone in CombiGene’s epilepsy project CG01 with delivery of first DNA plasmid

Production method of plasmids developed and first plasmid produced for gene therapy drug candidate aimed at treating drug resistant focal epilepsy

Cobra Biologics is proud to be part of a consortium to rapidly develop a COVID-19 vaccine

• ChAdOx1 consortium, led by the Jenner Institute, working to produce adenoviral vaccine • Fast-tracked clinical trials of ChAdOx1 to begin in April 2020